First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study
- Martínez-Calle, N.
- Alfonso, A.
- Rifón, J.
- Herrero, I.
- Errasti, P.
- Rábago, G.
- Merino, J.
- Panizo, Á.
- Pardo, J.
- Prósper, F.
- García-Muñoz, R.
- Lecumberri, R.
- Panizo, C.
ISSN: 1600-0609, 0902-4441
Année de publication: 2017
Volumen: 98
Número: 1
Pages: 38-43
Type: Article